Oxidoreductase, saccharopine dehydrogenase, putative
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 9 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 12 |
| NetGPI | no | yes: 0, no: 12 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005811 | lipid droplet | 5 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0016020 | membrane | 2 | 1 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4I3C3
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006629 | lipid metabolic process | 3 | 1 |
| GO:0006643 | membrane lipid metabolic process | 4 | 1 |
| GO:0006664 | glycolipid metabolic process | 5 | 1 |
| GO:0008152 | metabolic process | 1 | 1 |
| GO:0008610 | lipid biosynthetic process | 4 | 1 |
| GO:0009058 | biosynthetic process | 2 | 1 |
| GO:0009247 | glycolipid biosynthetic process | 5 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0044237 | cellular metabolic process | 2 | 1 |
| GO:0044238 | primary metabolic process | 2 | 1 |
| GO:0044249 | cellular biosynthetic process | 3 | 1 |
| GO:0044255 | cellular lipid metabolic process | 3 | 1 |
| GO:0046467 | membrane lipid biosynthetic process | 4 | 1 |
| GO:0071704 | organic substance metabolic process | 2 | 1 |
| GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
| GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 1 |
| GO:1901576 | organic substance biosynthetic process | 3 | 1 |
| GO:1903509 | liposaccharide metabolic process | 4 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 10 |
| GO:0016491 | oxidoreductase activity | 2 | 10 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 114 | 116 | PF00675 | 0.388 |
| CLV_NRD_NRD_1 | 235 | 237 | PF00675 | 0.310 |
| CLV_NRD_NRD_1 | 25 | 27 | PF00675 | 0.332 |
| CLV_NRD_NRD_1 | 278 | 280 | PF00675 | 0.330 |
| CLV_NRD_NRD_1 | 346 | 348 | PF00675 | 0.465 |
| CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.327 |
| CLV_PCSK_KEX2_1 | 235 | 237 | PF00082 | 0.351 |
| CLV_PCSK_KEX2_1 | 278 | 280 | PF00082 | 0.330 |
| CLV_PCSK_KEX2_1 | 315 | 317 | PF00082 | 0.339 |
| CLV_PCSK_PC1ET2_1 | 315 | 317 | PF00082 | 0.408 |
| CLV_PCSK_SKI1_1 | 279 | 283 | PF00082 | 0.429 |
| CLV_PCSK_SKI1_1 | 284 | 288 | PF00082 | 0.429 |
| CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.179 |
| DEG_COP1_1 | 50 | 58 | PF00400 | 0.273 |
| DOC_CKS1_1 | 355 | 360 | PF01111 | 0.292 |
| DOC_MAPK_gen_1 | 369 | 377 | PF00069 | 0.343 |
| DOC_MAPK_MEF2A_6 | 48 | 55 | PF00069 | 0.385 |
| DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.425 |
| DOC_USP7_MATH_1 | 169 | 173 | PF00917 | 0.418 |
| DOC_USP7_MATH_1 | 195 | 199 | PF00917 | 0.470 |
| DOC_USP7_MATH_1 | 299 | 303 | PF00917 | 0.402 |
| DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.385 |
| DOC_USP7_UBL2_3 | 27 | 31 | PF12436 | 0.316 |
| DOC_USP7_UBL2_3 | 344 | 348 | PF12436 | 0.466 |
| DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.293 |
| DOC_WW_Pin1_4 | 164 | 169 | PF00397 | 0.481 |
| DOC_WW_Pin1_4 | 189 | 194 | PF00397 | 0.441 |
| DOC_WW_Pin1_4 | 204 | 209 | PF00397 | 0.455 |
| DOC_WW_Pin1_4 | 354 | 359 | PF00397 | 0.287 |
| LIG_14-3-3_CanoR_1 | 18 | 24 | PF00244 | 0.373 |
| LIG_14-3-3_CanoR_1 | 235 | 241 | PF00244 | 0.431 |
| LIG_14-3-3_CanoR_1 | 260 | 270 | PF00244 | 0.520 |
| LIG_14-3-3_CanoR_1 | 347 | 352 | PF00244 | 0.467 |
| LIG_Actin_WH2_2 | 336 | 354 | PF00022 | 0.385 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.442 |
| LIG_BRCT_BRCA1_1 | 282 | 286 | PF00533 | 0.268 |
| LIG_DLG_GKlike_1 | 347 | 355 | PF00625 | 0.366 |
| LIG_eIF4E_1 | 328 | 334 | PF01652 | 0.355 |
| LIG_FHA_1 | 108 | 114 | PF00498 | 0.249 |
| LIG_FHA_1 | 14 | 20 | PF00498 | 0.310 |
| LIG_FHA_1 | 235 | 241 | PF00498 | 0.288 |
| LIG_FHA_1 | 377 | 383 | PF00498 | 0.522 |
| LIG_FHA_1 | 55 | 61 | PF00498 | 0.399 |
| LIG_FHA_1 | 73 | 79 | PF00498 | 0.134 |
| LIG_FHA_1 | 99 | 105 | PF00498 | 0.249 |
| LIG_FHA_2 | 185 | 191 | PF00498 | 0.492 |
| LIG_Integrin_isoDGR_2 | 217 | 219 | PF01839 | 0.404 |
| LIG_LIR_Gen_1 | 254 | 263 | PF02991 | 0.373 |
| LIG_LIR_Gen_1 | 264 | 274 | PF02991 | 0.317 |
| LIG_LIR_Nem_3 | 254 | 258 | PF02991 | 0.474 |
| LIG_LIR_Nem_3 | 264 | 269 | PF02991 | 0.442 |
| LIG_MLH1_MIPbox_1 | 282 | 286 | PF16413 | 0.268 |
| LIG_NRP_CendR_1 | 389 | 392 | PF00754 | 0.506 |
| LIG_Pex14_2 | 220 | 224 | PF04695 | 0.409 |
| LIG_Pex14_2 | 303 | 307 | PF04695 | 0.389 |
| LIG_PTB_Apo_2 | 214 | 221 | PF02174 | 0.396 |
| LIG_SH2_GRB2like | 215 | 218 | PF00017 | 0.469 |
| LIG_SH2_PTP2 | 266 | 269 | PF00017 | 0.333 |
| LIG_SH2_SRC | 215 | 218 | PF00017 | 0.410 |
| LIG_SH2_SRC | 247 | 250 | PF00017 | 0.254 |
| LIG_SH2_STAP1 | 328 | 332 | PF00017 | 0.420 |
| LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.274 |
| LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.286 |
| LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.222 |
| LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.334 |
| LIG_SH2_STAT5 | 247 | 250 | PF00017 | 0.255 |
| LIG_SH2_STAT5 | 266 | 269 | PF00017 | 0.467 |
| LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.393 |
| LIG_SH2_STAT5 | 328 | 331 | PF00017 | 0.304 |
| LIG_SH3_3 | 352 | 358 | PF00018 | 0.317 |
| LIG_SH3_3 | 85 | 91 | PF00018 | 0.285 |
| LIG_SUMO_SIM_anti_2 | 155 | 161 | PF11976 | 0.339 |
| LIG_SUMO_SIM_anti_2 | 192 | 198 | PF11976 | 0.461 |
| LIG_SUMO_SIM_anti_2 | 264 | 271 | PF11976 | 0.365 |
| LIG_SUMO_SIM_anti_2 | 3 | 9 | PF11976 | 0.361 |
| LIG_SUMO_SIM_par_1 | 192 | 198 | PF11976 | 0.403 |
| LIG_SUMO_SIM_par_1 | 378 | 383 | PF11976 | 0.496 |
| LIG_WRC_WIRS_1 | 55 | 60 | PF05994 | 0.385 |
| MOD_CDK_SPxK_1 | 204 | 210 | PF00069 | 0.357 |
| MOD_CDK_SPxxK_3 | 107 | 114 | PF00069 | 0.273 |
| MOD_CK1_1 | 172 | 178 | PF00069 | 0.299 |
| MOD_CK1_1 | 376 | 382 | PF00069 | 0.440 |
| MOD_CK2_1 | 225 | 231 | PF00069 | 0.472 |
| MOD_CK2_1 | 319 | 325 | PF00069 | 0.326 |
| MOD_Cter_Amidation | 313 | 316 | PF01082 | 0.468 |
| MOD_GlcNHglycan | 243 | 246 | PF01048 | 0.419 |
| MOD_GlcNHglycan | 312 | 315 | PF01048 | 0.374 |
| MOD_GlcNHglycan | 321 | 324 | PF01048 | 0.368 |
| MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.332 |
| MOD_GSK3_1 | 13 | 20 | PF00069 | 0.362 |
| MOD_GSK3_1 | 236 | 243 | PF00069 | 0.429 |
| MOD_GSK3_1 | 280 | 287 | PF00069 | 0.479 |
| MOD_GSK3_1 | 73 | 80 | PF00069 | 0.312 |
| MOD_N-GLC_1 | 172 | 177 | PF02516 | 0.446 |
| MOD_N-GLC_1 | 184 | 189 | PF02516 | 0.483 |
| MOD_N-GLC_1 | 98 | 103 | PF02516 | 0.341 |
| MOD_NEK2_1 | 10 | 15 | PF00069 | 0.285 |
| MOD_NEK2_1 | 223 | 228 | PF00069 | 0.415 |
| MOD_NEK2_1 | 240 | 245 | PF00069 | 0.284 |
| MOD_NEK2_1 | 251 | 256 | PF00069 | 0.451 |
| MOD_NEK2_1 | 259 | 264 | PF00069 | 0.292 |
| MOD_NEK2_1 | 286 | 291 | PF00069 | 0.489 |
| MOD_NEK2_1 | 298 | 303 | PF00069 | 0.371 |
| MOD_NEK2_2 | 17 | 22 | PF00069 | 0.385 |
| MOD_NEK2_2 | 299 | 304 | PF00069 | 0.360 |
| MOD_OFUCOSY | 72 | 77 | PF10250 | 0.273 |
| MOD_PIKK_1 | 37 | 43 | PF00454 | 0.360 |
| MOD_PKA_1 | 347 | 353 | PF00069 | 0.380 |
| MOD_PKA_2 | 17 | 23 | PF00069 | 0.385 |
| MOD_PKA_2 | 218 | 224 | PF00069 | 0.319 |
| MOD_PKA_2 | 234 | 240 | PF00069 | 0.204 |
| MOD_PKA_2 | 259 | 265 | PF00069 | 0.512 |
| MOD_Plk_1 | 317 | 323 | PF00069 | 0.428 |
| MOD_Plk_4 | 155 | 161 | PF00069 | 0.449 |
| MOD_Plk_4 | 236 | 242 | PF00069 | 0.322 |
| MOD_Plk_4 | 262 | 268 | PF00069 | 0.450 |
| MOD_Plk_4 | 338 | 344 | PF00069 | 0.357 |
| MOD_Plk_4 | 376 | 382 | PF00069 | 0.468 |
| MOD_Plk_4 | 54 | 60 | PF00069 | 0.378 |
| MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.293 |
| MOD_ProDKin_1 | 164 | 170 | PF00069 | 0.482 |
| MOD_ProDKin_1 | 189 | 195 | PF00069 | 0.438 |
| MOD_ProDKin_1 | 204 | 210 | PF00069 | 0.452 |
| MOD_ProDKin_1 | 354 | 360 | PF00069 | 0.291 |
| MOD_SUMO_for_1 | 47 | 50 | PF00179 | 0.341 |
| MOD_SUMO_rev_2 | 228 | 234 | PF00179 | 0.317 |
| MOD_SUMO_rev_2 | 383 | 391 | PF00179 | 0.490 |
| TRG_ENDOCYTIC_2 | 266 | 269 | PF00928 | 0.333 |
| TRG_ER_diArg_1 | 113 | 115 | PF00400 | 0.420 |
| TRG_ER_diArg_1 | 234 | 236 | PF00400 | 0.305 |
| TRG_ER_diArg_1 | 277 | 279 | PF00400 | 0.325 |
| TRG_ER_diLys_1 | 389 | 392 | PF00400 | 0.598 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HYN7 | Leptomonas seymouri | 62% | 100% |
| A0A0S4IJU8 | Bodo saltans | 41% | 99% |
| A0A1X0NQA2 | Trypanosomatidae | 43% | 99% |
| A0A3R7KXD1 | Trypanosoma rangeli | 46% | 100% |
| A0A3S7X166 | Leishmania donovani | 99% | 100% |
| A0A422NEM4 | Trypanosoma rangeli | 41% | 100% |
| A0PQ21 | Mycobacterium ulcerans (strain Agy99) | 29% | 94% |
| A1KMU7 | Mycobacterium bovis (strain BCG / Pasteur 1173P2) | 30% | 94% |
| A4HG79 | Leishmania braziliensis | 84% | 100% |
| A5U6W1 | Mycobacterium tuberculosis (strain ATCC 25177 / H37Ra) | 30% | 94% |
| E9AZJ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
| O53176 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 34% | 94% |
| P9WGV4 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 30% | 94% |
| P9WGV5 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 30% | 94% |
| Q3T067 | Bos taurus | 29% | 91% |
| Q4Q8N2 | Leishmania major | 96% | 100% |
| Q5R5C9 | Pongo abelii | 29% | 91% |
| Q6AY30 | Rattus norvegicus | 29% | 91% |
| Q7D745 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 34% | 94% |
| Q7TXK2 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 30% | 94% |
| Q8LGI2 | Arabidopsis thaliana | 27% | 86% |
| Q8NBX0 | Homo sapiens | 29% | 91% |
| Q8R127 | Mus musculus | 29% | 91% |
| Q9CD87 | Mycobacterium leprae (strain TN) | 30% | 94% |
| Q9GZE9 | Caenorhabditis elegans | 26% | 92% |
| V5AMR3 | Trypanosoma cruzi | 40% | 100% |
| V5CHW2 | Trypanosoma cruzi | 40% | 100% |